Merck (MRK) Interest Coverage Ratio (2011 - 2013)
Merck's (MRK) quarterly Interest Coverage Ratio came in at 9.23 in Q1 2013, down 36.36% year-over-year from 14.51 in Q1 2012, and down 0.99% quarter-over-quarter from 9.33 in Q4 2012.
Analysis
Merck (MRK) Interest Coverage Ratio (2011 - 2013) Analysis & Trends
Merck (MRK) has reported Interest Coverage Ratio for 3 consecutive years, with 9.23 the latest figure, recorded in Q1 2013.
- On a quarterly basis, Interest Coverage Ratio fell 36.36% year-over-year to 9.23 in Q1 2013; TTM through Mar 2013 was 11.56, a 0.36% change from a year earlier, with the FY2012 full-year figure at 12.9, up 16.92% from the prior year.
- Interest Coverage Ratio was 9.23 for Q1 2013 at Merck, down from 9.33 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 15.35 in Q2 2012 and troughed at 8.45 in Q4 2011.
- A 3-year average of 11.61 and a median of 11.9 in 2011 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio surged 50.19% in 2012 and tumbled 36.36% in 2013, its largest moves.
- Over 3 years, Interest Coverage Ratio stood at 8.45 in 2011, then increased by 10.36% to 9.33 in 2012, then retreated by 0.99% to 9.23 in 2013.
- The last three Interest Coverage Ratio figures came in at 9.23 (Q1 2013), 9.33 (Q4 2012), and 12.7 (Q3 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -21.24 |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 114.07 |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | 52.24 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 9.23 |
| Dec 31, 2012 | 9.33 |
| Sep 30, 2012 | 12.70 |
| Jun 30, 2012 | 15.35 |
| Mar 31, 2012 | 14.51 |
| Dec 31, 2011 | 8.45 |
| Sep 30, 2011 | 12.82 |
| Jun 30, 2011 | 10.22 |
| Mar 31, 2011 | 11.90 |